openPR Logo
Press release

Non-Radiographic Axial Spondyloarthritis Therapeutics Market Outlook and Key Players Insights - Kyowa Kirin Co. Ltd., Allergan, Amgen Inc, Astellas Pharma Inc, AstraZeneca, Daiichi Sankyo Company Limited, Eli Lilly and Company, Teijin Pharma Limited

04-13-2020 01:27 PM CET | IT, New Media & Software

Press release from: Data Bridge Market Research Pvt. Ltd.

The Non-Radiographic Axial Spondyloarthritis Therapeutics Market report takes into consideration key developments, company overview, SWOT analysis, investment feasibility analysis, and development trend analysis which may give the effective boost to the business in order to offer new openings and welcomes new players including both start-ups and established firms. To gain insightful analysis and to have comprehensive understanding of the Non-Radiographic Axial Spondyloarthritis Therapeutics market and its commercial landscape, this market report proves to be very beneficial. The product portfolios of all companies profiled in the report are compared in detail in the product analysis section. The Non-Radiographic Axial Spondyloarthritis Therapeutics Market report also provides market price analysis and value chain features.

This Non-Radiographic Axial Spondyloarthritis Therapeutics market research report includes segmentation of the global market on the basis of application, technology, end users, and region where each segment gives a microscopic view of the market. The report endows with an in-depth investigation of the market driving factors, opportunities, restraints, and challenges for obtaining the crucial insight of the Healthcare industry. What's more, the Non-Radiographic Axial Spondyloarthritis Therapeutics market research report also presents an in-depth explanation of the emerging trends in the global market and the unsettling technologies that could be key areas for investment. On the whole, the study of this market report offers an in-depth overview of the worldwide market covering all major parameters.

Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-radiographic-axial-spondyloarthritis-therapeutics-market&rp

Market Analysis: Global Non-Radiographic Axial Spondyloarthritis Therapeutics Market

Global non-radiographic axial spondyloarthritis therapeutics market is rising gradually registering a substantial in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. The emergence of drugs used in the treatment of celiac disease, inflammatory bowel disease, hyperthyroidism, chronic obstructive pulmonary disease (COPD) and bone marrow cancer, growing aging population are the key drivers for market growth.

Key Non-Radiographic Axial Spondyloarthritis Therapeutics Market Players:

Few of the major competitors currently working in the global non-radiographic axial spondyloarthritis therapeutics market are Kyowa Kirin Co., Ltd., Allergan, Amgen Inc, Astellas Pharma Inc, AstraZeneca, Daiichi Sankyo Company, Limited, Eli Lilly and Company, Teijin Pharma Limited, Stelis Biopharma, Radius Health, Inc, Pfizer Inc, Ono Pharmaceutical Co., Ltd, Novartis AG, Mochida Pharmaceutical Co., Ltd, Mereo BioPharma Group plc, Merck & Co., Inc, Gedeon Richter (UK) Ltd, F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, Cipla Inc, UCB SA, Teva Pharmaceutical Industries Ltd and among others.

The report covers exhaustive analysis on:

Non-Radiographic Axial Spondyloarthritis Therapeutics Market Segments
Non-Radiographic Axial Spondyloarthritis Therapeutics Market Dynamics
Non-Radiographic Axial Spondyloarthritis Therapeutics Market Size
Non-Radiographic Axial Spondyloarthritis Therapeutics Volume Analysis
Non-Radiographic Axial Spondyloarthritis Therapeutics Adoption Rare
Non-Radiographic Axial Spondyloarthritis Therapeutics Current Trends/Issues/Challenges
Non-Radiographic Axial Spondyloarthritis Therapeutics Competition & Companies involved
Non-Radiographic Axial Spondyloarthritis Therapeutics Value Chain

Want Full Report? Enquire Here https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-non-radiographic-axial-spondyloarthritis-therapeutics-market&rp

Market Definition: Global Non-Radiographic Axial Spondyloarthritis Therapeutics Market

Non-radiographic axial spondyloarthritis is a type of inflammatory arthritis, a hetrogenous group of autoimmune disorders that causes pain in lower back. The non-radiographic means that the symptoms or inflammation will not visible on x-ray (radiograph) but can show on MRI (magnetic resonance imaging) scan however it can negative too and axial spondyloarthritis means arthritis affect mainly on the spine. The patients with non- radiographic axial spondyloarthritis experience the severe back pain.

According to the statistics puplished in the UCB S.A., an estimated adult population of non-radiographic axial spondyloarthritis is up to 0.5% to 1.4%. Growing incidence of non-radiographic axial spondyloarthritis, accelerating demand of novel therapies and treatment are the key drivers for market growth

Segmentation: Global Non-Radiographic Axial Spondyloarthritis Therapeutics Market

Non-Radiographic Axial Spondyloarthritis Therapeutics Market : By Treatment Type

Medication
Surgery
Physical Therapy

Non-Radiographic Axial Spondyloarthritis Therapeutics Market : By Drugs

Secukinumab
Etanercept
Infliximab
Others

Non-Radiographic Axial Spondyloarthritis Therapeutics Market : By Route of Administration

Oral
Intravenous
Subcutaneous

Non-Radiographic Axial Spondyloarthritis Therapeutics Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

Non-Radiographic Axial Spondyloarthritis Therapeutics Market : By Geography

North America:

U.S.
Canada
Mexico

South America:

Brazil
Rest of South America

Europe:

Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe

Asia-Pacific:

Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific

Middle East & Africa:

South Africa
Rest of Middle East & Africa

Key Developments in the Non-Radiographic Axial Spondyloarthritis Therapeutics Market:

In June 2019, Kyowa Kirin Co., Ltd reported positive results of phase III, multi-regional, randomized, double-blind, placebo-controlled clinical study for brodalumab (KHK4827) evaluating for the treatment of non-radiographic axial spondyloarthritis. The trial has demonstrated that brodalumab was well tolerated in 16 weeks and effective. If successful, will be a novel option for the treatment of non-radiographic axial spondyloarthritis.

In March 2019, UCB SA received the US FDA approval for Cimzia (certolizumab pegol), EGylated anti-TNF (Tumor Necrosis Factor) for the treatment of non-radiographic axial spondyloarthritis.The FDA approval of Cimzia represents the significant treatment options for patients suffering from osteoporosis non-radiographic axial spondyloarthritis across the globe.

Non-Radiographic Axial Spondyloarthritis Therapeutics Market Drivers:

Increases prevalence of non-radiographic axial spondyloarthritis worldwide can enhance the market growth
Vulnerable adult population can also act as a market driver
Accelerates demand of novel therapies and newer development is driving the growth of this market
Strategic collaboration and licensing deal between the companies safety is enhancing the market growth

Non-Radiographic Axial Spondyloarthritis Therapeutics Market Restraints:

Effective treatment is either unavailable or unaffordable.
Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth if the market
Inadequate knowledge about non-radiographic axial spondyloarthritis in some developing countries

Competitive Analysis:

Global non-radiographic axial spondyloarthritis therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global non-radiographic axial spondyloarthritis therapeutics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Research Methodology: Global Non-Radiographic Axial Spondyloarthritis Therapeutics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

Current and future of Global non-radiographic axial spondyloarthritis therapeutics market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Non-Radiographic Axial Spondyloarthritis Therapeutics Market : Product Synopsis :

Chapter 1 - Executive Summary

Chapter 2 - Market Overview

Chapter 3 - Market Analysis & Opportunity Assessment , By Product Type

Chapter 4 - Market Analysis & Opportunity Assessment , By Matrix Type

Chapter 5 - Global Non-Radiographic Axial Spondyloarthritis Therapeutics Market Analysis & Opportunity Assessment , By Application

Chapter 6 - Market Analysis & Opportunity Assessment , By End User

Chapter 7 - Market Analysis & Opportunity Assessment , By Region

Chapter 8 - North America Market Analysis & Opportunity Assessment

Chapter 9 - Latin America Market Analysis & Opportunity Assessment

Chapter 10 - Western Europe Market Analysis & Opportunity Assessment

Chapter 11 - Eastern Europe Market Analysis & Opportunity Assessment

Chapter 12 - Asia Pacific Excluding Japan, China & South Korea Market Analysis & Opportunity Assessment

Chapter 13 - Japan Market Analysis & Opportunity Assessment

Chapter 14 - China Market Analysis & Opportunity Assessment

Chapter 15 - South Korea Market Analysis & Opportunity Assessment

Chapter 16 - MEA Market Analysis & Opportunity Assessment

Chapter 17 - Competition Landscape, Company Share and Company Profiles

Chapter 18 - Assumptions and Acronyms

Chapter 19 - Research Methodology

Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc/?dbmr=global-non-radiographic-axial-spondyloarthritis-therapeutics-market&rp

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Radiographic Axial Spondyloarthritis Therapeutics Market Outlook and Key Players Insights - Kyowa Kirin Co. Ltd., Allergan, Amgen Inc, Astellas Pharma Inc, AstraZeneca, Daiichi Sankyo Company Limited, Eli Lilly and Company, Teijin Pharma Limited here

News-ID: 2008216 • Views:

More Releases from Data Bridge Market Research Pvt. Ltd.

The Digital Landscape: Examining the Surge in Media Monitoring Software Market Valuation to USD 7584.77 Million by 2029 with a Striking CAGR of 14.40
The Digital Landscape: Examining the Surge in Media Monitoring Software Market V …
For an excellent business growth, companies must take up market research report service which is imperative in today's market place. "Media Monitoring Software Market" research report has been produced with a nice blend of industry insight, smart and practical solutions and newest technology to endow with the better user experience. The report brings into focus several aspects related to industry and market. A few of these can be listed here
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Animal Antibiotics Antimicrobials Market Sales to Top USD 6.3 billion by 2029
Antimicrobials are substances that kill or inhibit the majority of germs. The antimicrobials can be natural, semi-synthetic, or synthetic. Antibiotics are all antimicrobials, but antimicrobials aren't all antibiotics. Antibiotics are basically used to treat clinical illness, prevent and manage common disease occurrences, and improve animal development and growth. They are used in food animals in three ways: therapeutic, prophylactic, and sub-therapeutic. Antimicrobials offer significant advantages in terms of animal
Benzene Market Research 2021-2028: China National Petroleum Corporation, Haldia …
Market research reports help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions and reduce the risk of failure. In the world class Benzene market report, data collection modules with large sample sizes are used to collect data and perform base year analysis. The market research data included in this report is analysed and forecasted using market statistical and coherent models.
Digital Inks Market Report 2021-2027: Cabot Corporation, INX International Ink C …
Digital Inks Market research reports are very influential in many ways to grow the business. Digital Inks market report is a superior and comprehensive market research report which endows professionals with a lot of aspects about the market and the industry. The marketing report presents market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and

All 5 Releases


More Releases for Axial

Transformative Trends Impacting the Axial Lead Capacitors Market Landscape: Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Axial Lead Capacitors Market Size By 2025? The market size for axial lead capacitors has seen robust growth in the past years. The market is projected to increase from $0.98 billion in 2024 to $1.04 billion in 2025, with a compound annual growth rate (CAGR)
Six Axial Simulation Table Market Size Analysis by Application, Type, and Region …
According to Market Research Intellect, the global Six Axial Simulation Table market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The six axial simulation table market is experiencing notable growth due to its expanding use in
Axial Flow Pump Market Fueled By Growing Freshwater Needs: An Emerging Driver Tr …
The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Axial Flow Pump Market? The Axial Flow Pump Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Axial Spondyloarthritis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Axial Spondyloarthritis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Axial Spondyloarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Axial Spondyloarthritis Research. Learn more about
Axial Flow Pump Market Reaches $44B by 2031
Axial Flow Pump Market Scope: Key Insights : Axial Flow Pump Market size was valued at USD 29.83 billion in 2022 and is poised to grow from USD 31.14 billion in 2023 to USD 43.95 billion by 2031, growing at a CAGR of 4.4% during the forecast period (2024-2031). Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/axial-flow-pump-market In-Depth Exploration of the global Axial Flow Pump Market: This report
Axial Extensometers Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Axial Extensometers Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Axial Extensometers players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Axial Extensometers with respect to individual growth